Novo Nordisk’s unsolicited bid for Metsera came a month after Pfizer’s deal with the firm. Pfizer said it will ‘pursue all legal avenues’ to protect its rights.
A federal district judge previously ruled that ‘the provocative nature of ICE’s enforcement activity has caused a significant increase in protest activity.’